Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 98

    Brand-name drug prices rising at slower pace, lower amounts: AP Analysis

    Brand-name drug prices rising at slower pace, lower amounts: AP Analysis

    Medical Dialogues Bureau29 Aug 2019 3:32 PM IST
    After years of frequent list price hikes, many drugmakers are showing some restraint, according to the analysis of drug prices provided by health...
    FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients

    FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients

    Medical Dialogues Bureau29 Aug 2019 9:35 AM IST
    The U.S. Food and Drug Administration said on Wednesday it had identified 63 cases of worsening liver function in certain patients taking hepatitis C...
    Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

    Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

    Medical Dialogues Bureau29 Aug 2019 9:25 AM IST
    OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company...
    Regulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale, distribution of drugs

    Regulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale, distribution of drugs

    Medical Dialogues Bureau28 Aug 2019 5:04 PM IST
    New Delhi: In light of concerns raised in various forums, the Drugs Technical Advisory Board (DTAB) has recently recommended for finalization of the...
    Chemist license suspended for selling MTP pills sans prescription

    Chemist license suspended for selling MTP pills sans prescription

    Farhat Nasim28 Aug 2019 4:35 PM IST
    Indore: In a major crackdown, a chemist has been nabbed for selling abortion pills without medical prescription. The authority has suspended his...
    Unichem gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder

    Unichem gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder

    Farhat Nasim28 Aug 2019 2:39 PM IST
    Solifenacin Succinate Tablet is a generic version of Vesicare Tablets of Astellas Pharma US, Unichem said.New Delhi: Drug firm Unichem Laboratories...
    Revised drug law to pave way for cheap Indian generic medicines in China: Report

    Revised drug law to pave way for cheap Indian generic medicines in China: Report

    Medical Dialogues Bureau28 Aug 2019 9:45 AM IST
    India has been demanding that China open its pharmaceutical market to Indian drugs as part of the efforts to lower the USD 57 billion trade deficit in...
    Ipca Labs gets 3 USFDA observations for Silvassa unit

    Ipca Labs gets 3 USFDA observations for Silvassa unit

    Medical Dialogues Bureau28 Aug 2019 9:30 AM IST
    In a regulatory filing to BSE, Ipca Laboratories said the USFDA had conducted the inspection of its formulations manufacturing unit situated at...
    AstraZeneca gets USFDA fast track status for development of diabetes drug Farxiga

    AstraZeneca gets USFDA fast track status for development of diabetes drug Farxiga

    Medical Dialogues Bureau28 Aug 2019 9:15 AM IST
    Farxiga, one of AstraZeneca Plc's top 10 drugs by sales, is part of the SGLT2-inhibitor class of antidiabetics that cause the kidneys to expel blood...
    Purdue Pharma offers upto USD 12 billion to settle opioid claims

    Purdue Pharma offers upto USD 12 billion to settle opioid claims

    Farhat Nasim28 Aug 2019 9:00 AM IST
    U.S: OxyContin maker Purdue PharmaLP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the...
    CDSCO committee recommends exemption of chemical contraceptive FDC from Schedule H; Details

    CDSCO committee recommends exemption of chemical contraceptive FDC from Schedule H; Details

    Medical Dialogues Bureau27 Aug 2019 3:50 PM IST
    The said FDC of centchroman and ethinyloestradiol is a regular oral contraceptive pill sold under various brand names of contraceptive like Mala N,...
    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Farhat Nasim27 Aug 2019 2:30 PM IST
    "Strides Pharma Inc has acquired the manufacturing facility under an asset purchase agreement with Micelle Biopharma Inc for a consideration of USD...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok